Stockscreener 앱 받기
2.87
2.38%
-0.07
시간 외 거래:
2.88
0.010
+0.35%
전일 마감가:
$2.94
열려 있는:
$2.89
하루 거래량:
1.59M
Relative Volume:
1.09
시가총액:
$415.23M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-3.1871
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
-11.15%
1개월 성능:
-7.12%
6개월 성능:
+38.65%
1년 성능:
-63.06%
1일 변동 폭
$2.86
$2.955
1주일 범위
$2.86
$3.28
52주 변동 폭
$1.665
$8.29
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.87 | 425.35M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
Maravai LifeSciences Holdings Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Is Maravai LifeSciences Holdings Inc. stock supported by strong cash flowsWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will earnings trigger a reversal in Maravai LifeSciences Holdings Inc.2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure billEarnings Overview Report & Safe Entry Point Identification - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock enhance shareholder valueQuarterly Trade Report & Technical Pattern Recognition Alerts - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockMarket Growth Summary & Capital Protection Trading Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. stock a bargain at current levels2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Identifying reversal signals in Maravai LifeSciences Holdings Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Is Maravai LifeSciences Holdings Inc. stock ready for a breakoutQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investors2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025 - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Weekly Volume Report & Entry Point Confirmation Signals - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesQuarterly Trade Review & Reliable Breakout Forecasts - newser.com
Will Maravai LifeSciences Holdings Inc. stock gain from lower inflationWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. stock remains resilientQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
How moving averages guide Maravai LifeSciences Holdings Inc. tradingJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
Maravai Lifesciences stock hits 52-week low at $4.19 - MSN
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
How Maravai LifeSciences Holdings Inc. stock benefits from strong dollar2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
What technical signals suggest for Maravai LifeSciences Holdings Inc. stock2025 Volatility Report & Verified Entry Point Detection - newser.com
Using Ichimoku Cloud for Maravai LifeSciences Holdings Inc. technicals2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – DUS:MAR - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN
Maravai LifeSciences (MRVI) to Release Quarterly Earnings on Thursday - MarketBeat
Is Polysil Irrigation Systems Limited Stock Risky in the Current Market EnvironmentReal Estate Investment Trusts & Market Monitoring and Alerts - earlytimes.in
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):